Hemagglutinin Culture Medium for Pluripotent Stem Cell Proliferation

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current methods for culturing pluripotent stem cells face challenges in maintaining their undifferentiated state and promoting proliferation, as cells often deviate from this state during culture, leading to reduced efficiency and quality of stem cell production.

Innovation Solution

Incorporating hemagglutinin or modified hemagglutinin into the culture medium to reduce cell-cell adhesion, promoting uniform cell growth and preventing the emergence of differentiated cells, thereby enhancing proliferation and maintaining the undifferentiated state of pluripotent stem cells.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Quantity of substance

If pluripotent stem cells are cultured in large quantities, then the quantity of stem cells increases, but cells deviate from the undifferentiated state

Engineering Contradiction:
Improvequantity of stem cellsVSAvoidundifferentiated state maintenance
Core Design Contradiction:
Quantity of substanceVSReliability

Solution Approach 1:

Hemagglutinin serves as an intermediary substance that mediates between cell-cell adhesion and proliferation. It specifically binds to E-cadherin on cell surfaces, reducing adhesion strength to promote uniform cell distribution and proliferation while maintaining undifferentiated state, thus resolving the contradiction between increasing cell quantity and maintaining stem cell quality

Inventive Principle:
Principle #24Intermediary (Mediator)

Solution Approach 2:

The patent changes the adhesion parameter by introducing hemagglutinin which modifies cell-cell interaction dynamics. This parameter change reduces excessive adhesion that causes cell deviation, enabling large-scale culture while maintaining undifferentiated state through optimized adhesion control

Inventive Principle:
Principle #35Parameter changes

2Strength

If cell-cell adhesion is strong, then cells maintain structural integrity, but uniform cell growth is inhibited

Engineering Contradiction:
Improvecell-cell adhesionVSAvoiduniform cell growth
Core Design Contradiction:
StrengthVSManufacturing precision

Solution Approach 1:

Hemagglutinin modifies the adhesion parameter by binding to E-cadherin, reducing adhesion strength to an optimal level. This parameter change prevents excessive adhesion that causes non-uniform growth while maintaining sufficient adhesion for structural integrity, achieving uniform cell growth throughout the culture

Inventive Principle:
Principle #35Parameter changes

3Manufacturing precision

If hemagglutinin is added to reduce cell-cell adhesion, then uniform cell growth is promoted, but cell aggregation may be disrupted

Engineering Contradiction:
Improveuniform cell growthVSAvoidcell aggregate structure
Core Design Contradiction:
Manufacturing precisionVSStability of the object's composition

Solution Approach 1:

The patent optimizes the hemagglutinin concentration parameter to achieve the desired effect. By controlling the concentration within a specific range, it reduces adhesion sufficiently to promote uniform growth while maintaining enough structural integrity in cell aggregates, resolving the contradiction between uniformity and structural stability

Inventive Principle:
Principle #35Parameter changes

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The use of hemagglutinin or modified hemagglutinin in the culture medium effectively promotes the proliferation of pluripotent stem cells while maintaining their undifferentiated state, leading to higher cell density and uniformity, which improves the quality and efficiency of stem cell culture.

Implementation Method 1

These results may be attributed to the mechanism that hemagglutinin specifically binds to E-cadherin that is a cell adhesion molecule to inhibit cell-cell adhesion

Methodology Applied
Scientific EffectHemagglutinin binding to E-cadherin: Adhesive

Data Source

PatentUS11795438B2Composition for promoting proliferation of pluripotent stem cells, and method for promoting proliferation of pluripotent stem cells
Publication Date: 2023.10.24 OSAKA UNIVERSITY
  • US11795438B2 patent drawing
  • US11795438B2 patent drawing
  • US11795438B2 patent drawing

AI summary

Provided are a method for promoting the proliferation of pluripotent stem cells and a proliferation promoting composition used in the method. In one aspect, a composition for promoting the proliferation of pluripotent stem cells includes hemagglutinin or modified hemagglutinin. In another aspect, a method for promoting the proliferation of pluripotent stem cells includes culturing pluripotent stem cells in a culture medium to which the proliferation promoting composition of the present disclosure has been added.